Biotech CEOs "pledge of safety" mRNA and monkey adenoviral vector-based platforms to be used.

The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have "announced a historic pledge", outlining their commitment to upholding "the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines."

The pledge does not discuss the lack of long-term studies on the carcinogenic effects and impact on fertility of newly-developed vaccine technologies, such as mRNA or the monkey adenoviral vector-based platform.

The mRNA and monkey adenoviral vector-based platforms to be used by some BioTech companies have not been studied over a long period of time, unlike the human adenoviral vector-based platform used in Russia’s Sputnik V vaccine, it should stressed that public health and safety requires not only short-term evidence of lack of serious adverse effects but also safety and efficacy proved by the results of long-term studies" and not just a plege.

"While signing up to the 'pledge of safety', these companies are also pressuring the countries buying their vaccines into granting them full indemnification from lawsuits. We believe that international regulators should require long-term evidence of lack of serious adverse side effects when considering candidate vaccines for registration in their countries.

#PledgeOfSafety #mRNA #MonkeyAdenoviral #VectorBased #Covid19 #Vaccine